These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 6442501

  • 1. Anthrax: the disease in relation to vaccines.
    Cameron J.
    Vaccine; 1984 Dec; 2(4):237. PubMed ID: 6442501
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
    Chitlaru T, Israeli M, Rotem S, Elia U, Bar-Haim E, Ehrlich S, Cohen O, Shafferman A.
    Vaccine; 2017 Oct 20; 35(44):6030-6040. PubMed ID: 28342664
    [Abstract] [Full Text] [Related]

  • 5. Potency testing of anthrax spore vaccine (living) in guinea pigs.
    Jaiswal TN, Mittal KR.
    Indian Vet J; 1979 Mar 20; 56(3):199-201. PubMed ID: 113339
    [No Abstract] [Full Text] [Related]

  • 6. Immunizing activity of oil adjuvant attenuated spore vaccine of Bacillus anthracis in sheep.
    Al-Dabbass AH, Al-Abdali SM, Mahmoud AA, Muhamed MM.
    Zentralbl Veterinarmed B; 1986 Jun 20; 33(5):340-5. PubMed ID: 3096031
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
    Mendelson I, Gat O, Aloni-Grinstein R, Altboum Z, Inbar I, Kronman C, Bar-Haim E, Cohen S, Velan B, Shafferman A.
    Vaccine; 2005 Dec 01; 23(48-49):5688-97. PubMed ID: 16039760
    [Abstract] [Full Text] [Related]

  • 9. [Standardization of the seeding material in producing live anthrax vaccine].
    Gladus MA, Nikolaenko IuP, Lazareva ES, Fatkhinurova TI, Mashilova GM.
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Sep 01; (9):42-6. PubMed ID: 106609
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Of spore opsonization and passive protection against anthrax.
    Goossens PL, Sylvestre P, Mock M.
    Microbiology (Reading); 2007 Feb 01; 153(Pt 2):301-2; discussion 302-4. PubMed ID: 17259600
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis.
    Yin Y, Zhang J, Dong D, Liu S, Guo Q, Song X, Li G, Fu L, Xu J, Chen W.
    Vaccine; 2008 Oct 29; 26(46):5814-21. PubMed ID: 18786589
    [Abstract] [Full Text] [Related]

  • 16. Anthrax vaccines: a development update.
    Little SF.
    BioDrugs; 2005 Oct 29; 19(4):233-45. PubMed ID: 16128606
    [Abstract] [Full Text] [Related]

  • 17. [Mixed vaccine against bacterial anthrax and symptomatic anthrax].
    Blancou JM.
    Rev Elev Med Vet Pays Trop; 1974 Oct 29; 27(2):183-7. PubMed ID: 4219888
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.